Victoria Sidoroff, Federico Carbone, Philipp Ellmerer, Stefanie Bair, Alexandra Hoffmann, Thomas Maran, Florian Krismer, Philipp Mahlknecht, Katherina Mair, Cecilia Raccagni, Jean-Pierre Ndayisaba, Klaus Seppi, Gregor K. Wenning, Atbin Djamshidian
J Mov Disord. 2024;17(1):38-46. Published online September 26, 2023
Objective Emotional processing is a core feature of social interactions and has been well studied in patients with idiopathic Parkinson’s disease (PD), albeit with contradictory results. However, these studies excluded patients with atypical parkinsonism, such as multiple system atrophy (MSA). The objective of this exploratory study was to provide better insights into emotion processing in patients with MSA using eye tracking data.
Methods We included 21 MSA patients, 15 PD patients and 19 matched controls in this study. Participants performed a dynamic and a static emotion recognition task, and gaze fixations were analyzed in different areas of interest. Participants underwent neuropsychological testing and assessment of depression and alexithymia.
Results MSA patients were less accurate in recognizing anger than controls (p = 0.02) and had overall fewer fixations than controls (p = 0.001). In the static task, MSA patients had fewer fixations (p < 0.001) and a longer time to first fixation (p = 0.026) on the eye region. Furthermore, MSA patients had a longer fixation duration overall than PD patients (p = 0.004) and longer fixations on the nose than controls (p = 0.005). Alexithymia scores were higher in MSA patients compared to controls (p = 0.038).
Conclusion This study demonstrated impaired recognition of anger in MSA patients compared to HCs. Fewer and later fixations on the eyes along with a center bias suggest avoidance of eye contact, which may be a characteristic gaze behavior in MSA patients.
Objective Olfactory and emotional dysfunctions are very common in patients with Parkinson’s disease (PD). Olfaction and emotions share common neuroanatomical substrates. Therefore, in this study, we evaluated the association between olfactory and emotional dysfunctions in patients with PD. Methods Parkinson’s disease patients who had been assessed for their olfactory function and neuropsychiatric symptoms including emotional dysfunction were included. A logistic regression analysis was performed to evaluate the association between low olfaction and different neuropsychiatric symptoms. Results The patients with low olfaction (cross cultural smell identification test score ≤ 6) showed a higher prevalence of apathy when compared with those with high olfaction, whereas the frequencies of other neuropsychiatric symptoms were comparable between the two groups. A multivariate logistic regression analysis revealed that the presence of apathy/indifference [odds ratio (OR) = 2.859, p = 0.007], age 70 years or more (OR = 2.281, p = 0.009), and the male gender (OR = 1.916, p = 0.030) were significantly associated with low olfaction. Conclusions Our results demonstrate that apathy/indifference is a unique emotional dysfunction associated with olfactory dysfunction in PD. The findings also suggest that PD patients with low olfaction have a high prevalence of apathy.
Citations
Citations to this article as recorded by
Clinical features and neurobiochemical mechanisms of olfactory dysfunction in patients with Parkinson disease Ruidan Wang, Tenghong Lian, Mingyue He, Peng Guo, Shuyang Yu, Lijun Zuo, Yang Hu, Wei Zhang Journal of Neurology.2024; 271(4): 1959. CrossRef
China’s Modified Version of Sniffin’ Sticks 12‐Identification Test Used in Chinese Parkinson’s Disease and Multiple System Patients: Comparison of Three Olfactory Testing Methods Huijing Liu, Wei Du, Shuhua Li, Ying Jin, Haibo Chen, Wen Su, Cristine Alves da Costa Parkinson's Disease.2024;[Epub] CrossRef
Neurons, Nose, and Neurodegenerative Diseases: Olfactory Function and Cognitive Impairment Irene Fatuzzo, Giovanni Francesco Niccolini, Federica Zoccali, Luca Cavalcanti, Mario Giuseppe Bellizzi, Gabriele Riccardi, Marco de Vincentiis, Marco Fiore, Carla Petrella, Antonio Minni, Christian Barbato International Journal of Molecular Sciences.2023; 24(3): 2117. CrossRef
Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson’s disease Fardin Nabizadeh, Kasra Pirahesh, Elham Khalili Neurological Sciences.2022; 43(7): 4193. CrossRef
The Power of Odor Persuasion: The Incorporation of Olfactory Cues in Virtual Environments for Personalized Relaxation Silvia Francesca Maria Pizzoli, Dario Monzani, Ketti Mazzocco, Emanuela Maggioni, Gabriella Pravettoni Perspectives on Psychological Science.2022; 17(3): 652. CrossRef
Olfaction and apathy in early idiopathic Parkinson's disease Alfonso E. Martinez-Nunez, Kaitie Latack, Miguel Situ-Kcomt, Abhimanyu Mahajan Journal of the Neurological Sciences.2022; 439: 120314. CrossRef
Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype Ségolène De Waele, Patrick Cras, David Crosiers Brain Sciences.2022; 12(7): 923. CrossRef
α‐Synuclein Spread from Olfactory Bulb Causes Hyposmia, Anxiety, and Memory Loss in BAC‐SNCA Mice Norihito Uemura, Jun Ueda, Toru Yoshihara, Masashi Ikuno, Maiko T. Uemura, Hodaka Yamakado, Masahide Asano, John Q. Trojanowski, Ryosuke Takahashi Movement Disorders.2021; 36(9): 2036. CrossRef
Hyposmia may predict development of freezing of gait in Parkinson’s disease Jae Jung Lee, Jin Yong Hong, Jong Sam Baik Journal of Neural Transmission.2021; 128(6): 763. CrossRef
Clinical and Dopamine Depletion Patterns in Hyposmia- and Dysautonomia-Dominant Parkinson’s Disease Han Soo Yoo, Sangwon Lee, Seong Ho Jeong, Byoung Seok Ye, Young H. Sohn, Mijin Yun, Phil Hyu Lee Journal of Parkinson's Disease.2021; 11(4): 1703. CrossRef
Is There a Shared Etiology of Olfactory Impairments in Normal Aging and Neurodegenerative Disease? Mahraz Parvand, Catharine H. Rankin, Lori Beason-Held Journal of Alzheimer's Disease.2020; 73(1): 1. CrossRef
Open questions on the nature of Parkinson’s disease: from triggers to spreading pathology Lei Mou, Wei Ding, Pedro Fernandez-Funez Journal of Medical Genetics.2020; 57(2): 73. CrossRef
Effect of Olfactory and Gustatory Dysfunction and Motor Symptoms on Body Weight in Patients with Parkinson’s Disease Carla Masala, Francesco Loy, Raffaella Piras, Anna Liscia, Laura Fadda, Alan Moat, Paolo Solla, Giovanni Defazio Brain Sciences.2020; 10(4): 218. CrossRef
Insula and Amygdala Atrophy Are Associated With Functional Impairment in Subjects With Presbycusis Chama Belkhiria, Rodrigo C. Vergara, Simón San Martin, Alexis Leiva, Melissa Martinez, Bruno Marcenaro, Maricarmen Andrade, Paul H. Delano, Carolina Delgado Frontiers in Aging Neuroscience.2020;[Epub] CrossRef
Contribution of Five Functional Loci of Dopamine Metabolism-Related Genes to Parkinson’s Disease and Multiple System Atrophy in a Chinese Population Yongping Chen, Ruwei Ou, Lingyu Zhang, Xiaojing Gu, Xiaoqin Yuan, Qian-qian Wei, Bei Cao, Bi Zhao, Ying Wu, Huifang Shang Frontiers in Neuroscience.2020;[Epub] CrossRef
Olfactory Dysfunction Predicts Disease Progression in Parkinson’s Disease: A Longitudinal Study Runcheng He, Yuwen Zhao, Yan He, Yangjie Zhou, Jinxia Yang, Xiaoting Zhou, Liping Zhu, Xun Zhou, Zhenhua Liu, Qian Xu, Qiying Sun, Jieqiong Tan, Xinxiang Yan, Beisha Tang, Jifeng Guo Frontiers in Neuroscience.2020;[Epub] CrossRef
Characteristics of apathy in treatment-naïve patients with Parkinson’s disease Hiroo Terashi, Yuki Ueta, Haruhisa Kato, Hiroshi Mitoma, Hitoshi Aizawa International Journal of Neuroscience.2019; 129(1): 16. CrossRef
Olfaction and taste in Parkinson’s disease: the association with mild cognitive impairment and the single cognitive domain dysfunction Maria Paola Cecchini, Angela Federico, Alice Zanini, Elisa Mantovani, Carla Masala, Michele Tinazzi, Stefano Tamburin Journal of Neural Transmission.2019; 126(5): 585. CrossRef
The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function Dragos Mihaila, Jordan Donegan, Sarah Barns, Daria LaRocca, Qian Du, Danny Zheng, Michael Vidal, Christopher Neville, Richard Uhlig, Frank A. Middleton, Brenda A Wilson PLOS ONE.2019; 14(6): e0218252. CrossRef
Hyposmia as a marker of (non-)motor disease severity in Parkinson’s disease Dareia S. Roos, Jos W. R. Twisk, Pieter G. H. M. Raijmakers, Richard L. Doty, Henk W. Berendse Journal of Neural Transmission.2019; 126(11): 1471. CrossRef
Correlation among olfactory function, motors’ symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson’s disease Carla Masala, Paolo Solla, A. Liscia, G. Defazio, L. Saba, A. Cannas, A. Cavazzana, T. Hummel, A. Haehner Journal of Neurology.2018; 265(8): 1764. CrossRef
Olfactory Dysfunction as an Early Biomarker in Parkinson’s Disease Michelle E. Fullard, James F. Morley, John E. Duda Neuroscience Bulletin.2017; 33(5): 515. CrossRef
Human behavioral assessments in current research of Parkinson’s disease Tetsuya Asakawa, Huan Fang, Kenji Sugiyama, Takao Nozaki, Susumu Kobayashi, Zhen Hong, Katsuaki Suzuki, Norio Mori, Yilin Yang, Fei Hua, Guanghong Ding, Guoqiang Wen, Hiroki Namba, Ying Xia Neuroscience & Biobehavioral Reviews.2016; 68: 741. CrossRef